Extending the Antiviral Value of Favipiravir

J Infect Dis. 2018 Jul 13;218(4):509-511. doi: 10.1093/infdis/jiy153.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amides
  • Antiviral Agents*
  • Humans
  • Lymphocytic choriomeningitis virus*
  • Pyrazines
  • Transplant Recipients

Substances

  • Amides
  • Antiviral Agents
  • Pyrazines
  • favipiravir